Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers

Clinical trial NCT07158346 · COMPLETED

Trial details

NCT number: NCT07158346
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-08-18
Primary completion: 2025-10-03
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.